{"disease":{"id":"mammographic-breast-density","name":"mammographic breast density"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03199963","title":"Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":223,"lead_sponsor_name":"BHR Pharma, LLC","has_results":true},{"nct_id":"NCT04498013","title":"Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Dr. Struk Tetiana","has_results":false},{"nct_id":"NCT04616430","title":"Topical Endoxifen in Women","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Atossa Therapeutics, Inc.","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}